Climb Bio (CLYM) Stock Research

Friday

Climb Bio price target raised by $8 at Truist

CLYM

Aug 7, 10:07 AM

Thursday

Climb Bio reports Q2 EPS (18c), consensus (21c)

CLYM

Aug 6, 7:29 AM

Over a week ago

Climb Bio initiated with bullish view at RBC Capital, here's why

CLYM

Aug 3, 6:07 AM

Climb Bio price target raised by $1 at BTIG, here's why

CLYM

Jun 11, 12:20 PM

Climb Bio announces initial data from budoprutug study at EHA

CLYM

Jun 11, 8:03 AM

Climb Bio initiated with bullish view at Guggenheim, here's why

Jun 8, 7:13 AM

Climb Bio registers to sell 11.59M shares of common stock for holders

CLYM

May 29, 4:10 PM

Climb Bio price target raised by $5 at H.C. Wainwright, here's why

CLYM

May 12, 6:13 AM

Climb Bio price target raised by $2 at Wedbush, here's why

CLYM

May 8, 9:39 AM

Climb Bio reports Q1 EPS (20c), consensus (31c)

CLYM

May 7, 7:15 AM

Climb Bio price target raised by $11 at BTIG, here's why

CLYM

May 6, 7:23 AM

Climb Bio price target raised by $9 at Baird, here's why

CLYM

May 6, 6:44 AM

Climb Bio initiated with bullish view at Chardan, here's why

CLYM

May 5, 4:02 AM

management to meet virtually with Piper Sandler

CLYM

Apr 30, 8:15 AM

Climb Bio management to meet with Piper Sandler

CLYM

Apr 28, 9:50 AM

Climb Bio to sell 9.481M shares at $9.50 in private placement

CLYM

Apr 28, 7:48 AM

Climb Bio price target raised by $8 at Oppenheimer, here's why

CLYM

Apr 21, 8:02 AM

Climb Bio initiated with bullish view at Mizuho, here's why

CLYM

Apr 15, 4:47 AM

Climb Bio granted Fast Track Designation to budoprutug by FDA

CLYM

Apr 7, 7:03 AM

Climb Bio management to meet with Piper Sandler

CLYM

Apr 2, 11:05 AM

Climb Bio initiated with bullish view at B. Riley, here's why

CLYM

Mar 24, 5:18 AM

Climb Bio initiated with bullish view at Truist, here's why

CLYM

Mar 17, 4:12 PM

Friday

Climb Bio price target raised by $8 at Truist

CLYM

Aug 7, 10:07 AM

Thursday

Climb Bio reports Q2 EPS (18c), consensus (21c)

CLYM

Aug 6, 7:29 AM

Over a week ago

Climb Bio initiated with bullish view at RBC Capital, here's why

CLYM

Aug 3, 6:07 AM

Climb Bio price target raised by $1 at BTIG, here's why

CLYM

Jun 11, 12:20 PM

Climb Bio announces initial data from budoprutug study at EHA

CLYM

Jun 11, 8:03 AM

Climb Bio initiated with bullish view at Guggenheim, here's why

Jun 8, 7:13 AM

Climb Bio registers to sell 11.59M shares of common stock for holders

CLYM

May 29, 4:10 PM

Climb Bio price target raised by $5 at H.C. Wainwright, here's why

CLYM

May 12, 6:13 AM

Climb Bio price target raised by $2 at Wedbush, here's why

CLYM

May 8, 9:39 AM

Climb Bio reports Q1 EPS (20c), consensus (31c)

CLYM

May 7, 7:15 AM

Climb Bio price target raised by $11 at BTIG, here's why

CLYM

May 6, 7:23 AM

Climb Bio price target raised by $9 at Baird, here's why

CLYM

May 6, 6:44 AM

Climb Bio initiated with bullish view at Chardan, here's why

CLYM

May 5, 4:02 AM

management to meet virtually with Piper Sandler

CLYM

Apr 30, 8:15 AM

Climb Bio management to meet with Piper Sandler

CLYM

Apr 28, 9:50 AM

Climb Bio to sell 9.481M shares at $9.50 in private placement

CLYM

Apr 28, 7:48 AM

Climb Bio price target raised by $8 at Oppenheimer, here's why

CLYM

Apr 21, 8:02 AM

Climb Bio initiated with bullish view at Mizuho, here's why

CLYM

Apr 15, 4:47 AM

Climb Bio granted Fast Track Designation to budoprutug by FDA

CLYM

Apr 7, 7:03 AM

Climb Bio management to meet with Piper Sandler

CLYM

Apr 2, 11:05 AM

Climb Bio initiated with bullish view at B. Riley, here's why

CLYM

Mar 24, 5:18 AM

Climb Bio initiated with bullish view at Truist, here's why

CLYM

Mar 17, 4:12 PM

Company News

Charts